Sildenafil Citrate NDC 82804-251

Product information

Brand name (proprietary)

Sildenafil Citrate

Generic name (nonproprietary)

sildenafil citrate

Active ingredients

Sildenafil citrate — 25 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Proficient Rx LP

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 209302

Marketing start

Jun 16, 2021

Listing expires

Dec 31, 2027

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 82804-251_9bec136a-1f3e-4c5a-85ce-6e490dacb939SPL ID 9bec136a-1f3e-4c5a-85ce-6e490dacb939

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482804025111 followed by a unit qualifier and the quantity Copy

Package 82804-0251-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 209302

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.